Physician profile
Constantine Nicholas Canoutas
NPI 1427095520
$5,546.00
in general payments reported to CMS, 2019-2025
34 companies · $776 in 2025
The $776 reported for 2025 was more than what 83% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $529 · 2021: $457 · 2022: $790 · 2023: $1,187 · 2024: $1,101 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,063.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,595.29 | 2019-2025 | Ortholoc 2 Lapifuse, Prostep, Augment Injectable |
| Organogenesis INC. | $491.04 | 2019-2025 | Via Matrix, Simplimax, Puraply |
| Paratek Pharmaceuticals, INC. | $469.95 | 2021-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $446.17 | 2023-2025 | Purified Cortrophin Gel |
| Zyla Life Sciences, INC. | $342.51 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $291.31 | 2022-2023 | Seglentis |
| Horizon Therapeutics Plc | $280.50 | 2019-2023 | Krystexxa |
| Convatec INC. | $269.69 | 2023-2024 | |
| Amgen INC. | $211.30 | 2024-2025 | Krystexxa |
| Treace Medical Concepts, INC. | $136.62 | 2022-2025 | |
| Paragon 28, INC. | $128.02 | 2019-2023 | Hammertube |
| Melinta Therapeutics, LLC | $97.01 | 2019 | |
| Medtronic, INC. | $86.05 | 2023-2025 | Intellis Adaptivestim |
| Grt US Holding, INC. | $80.25 | 2022 | |
| Smith+Nephew, INC. | $77.82 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $68.90 | 2023 | Xperience, Blastx, Surgx |
| Abbott Laboratories | $59.71 | 2020-2024 | Proclaim |
| Peerless Surgical INC. | $49.70 | 2023 | |
| Sebela Pharmaceuticals INC. | $42.67 | 2022-2023 | Naftin |
| Biowound Solutions, INC. | $36.36 | 2025 | Bio-Connekt |
| Nabriva Therapeutics, Plc | $32.64 | 2022 | |
| Advanced Oxygen Therapy INC. | $29.62 | 2023 | Topical Oxygen Chamber For Extremities |
| Wright Medical Technology, INC. | $26.90 | 2020 | |
| Medela LLC | $26.58 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $26.02 | 2019 | |
| Nevro Corp. | $25.48 | 2022 | |
| Acera Surgical, INC. | $22.39 | 2025 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $17.22 | 2025 | |
| Innovation Technologies INC | $15.14 | 2025 | Irrisept |
| Linvatec Corporation | $14.75 | 2019 | |
| Integra Lifesciences Corporation | $12.59 | 2020 | |
| Bioventus LLC | $12.44 | 2022 | |
| Zimmer Biomet Holdings, INC. | $11.76 | 2020 | |
| Heron Therapeutics, INC. | $11.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Canoutas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.